Stryde Research is heading to ACR Convergence 2026, the American College of Rheumatology’s annual meeting, in Orlando, Florida. We will be on the exhibit floor at booth 2633 from Sunday, November 8 through Tuesday, November 10, with four members of our team ready to talk rheumatology, autoimmune research, and cell and gene therapy. Come find us and say hello.
Event details
- Event: ACR Convergence 2026, November 6 to 11
- Stryde at the booth: Sunday, November 8 to Tuesday, November 10
- Booth: 2633
- Location: Orange County Convention Center, [9800 International Drive, Orlando, FL 32819]
- Registration: rheumatology.org/annual-meeting-registration
- Program and schedule: Online Program
- Want a set time with the team? Email trials@stryderesearch.com
Find our booth
Look for the Stryde Research banner at booth 2633 on the exhibit floor. Our team will be there every day from November 8 to 10, so there is always someone to talk to.
Whether you are a sponsor planning your next autoimmune study, a rheumatologist curious about adding research to your practice, or just walking the floor between sessions, you are welcome at our booth.
Why we are there
Stryde runs embedded clinical trial sites inside independent specialty practices, and rheumatology is emerging as one of our two core therapeutic areas. Because our studies happen in the practices where patients already receive care, the physician running the study is often the patient’s own rheumatologist.
We are currently supporting over 10 rheumatology/autoimmune trials, including SLE and Sjogren’s. Stryde also holds NIH IBC-RMS approval for cell and gene therapy studies, with an in-house medical monitor, as more of these programs move into rheumatology.
ACR Convergence brings the rheumatology community into one place, and we are excited to be part of it.
Who’s attending from Stryde
Four members of our team will be at the booth.
Edward Olko is Head of Business Development at Stryde, where he leads outreach and builds the relationships behind our sponsor partnerships. He is responsible for creating new partnerships with CROs and sponsors. He recently attended the Alliance for Regenerative Medicine’s Cell and Gene Meeting on the Mesa, so he’s a great person to talk to about cell and gene therapy.
Haein Kim, Ph.D. is Business Development Officer at Stryde, where she specializes in ongoing engagement with Stryde’s sponsor and CRO partners. Trained as a cell biologist, she has spent most of her career after academia working at the intersection of science, business, and patient advocacy, with a focus on relationship building and strategic alignment. Her experience includes cell and gene therapy investing and early-stage clinical development strategy. If you are an emerging biotech planning your next study, she is the person to talk to.
Laila Harruna, MPH, CPH is Senior Clinical Research Recruitment and Outreach Specialist at Stryde, based in Dallas-Fort Worth. She has presented her work at the American Public Health Association annual meeting. Ask her how our team connects patients with the right studies.
Marysia Wrona, M.D. is a Research Assistant II at Stryde Research. A medical graduate of Poznan University of Medical Sciences (PUMS), Poland, she brings a strong medical foundation and an interest in advancing healthcare. With hands-on experience at a rheumatology research site, she is a great person to connect with for practical insights into day-to-day site operations and the realities of conducting clinical trials.
These four will be at booth 2633 from November 8 to 10. Stop by, and chat, we’re happy to help.
Follow along
We will post photos and updates from Orlando on our social channels using #ACRConvergence, and we will publish a recap here on the blog once the meeting wraps. If you cannot make it to Orlando, follow along online. If you are at ACR Convergence, come find us at booth 2633.